Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides

Infection and Immunity

Volumn 72, Issue 9, 2004, Pages 5159-5167

  Belas, Robert ^a   Manos, Jim ^a   Suvanasuthi, Rooge ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIINFECTIVE AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLLAGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CYTOSKELETON PROTEIN; FIBRONECTIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMININ; METALLOPROTEINASE; METALLOPROTEINASE ZAPA; PROTEGRIN; TUBULIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEUS MIRABILIS; URINARY TRACT INFECTION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; ESCHERICHIA COLI; HUMANS; METALLOENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEINS; PROTEUS MIRABILIS; SUBSTRATE SPECIFICITY;

EID: 4544254599     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.9.5159-5167.2004     Document Type: Article

References (29)

1. Aneas, M. A., F. C. Portaro, I. Lebrun, L. Juliano, M. S. Palma, and B. L. Fernandes. 2001. ZapA, a possible virulence factor from Proteus mirabilis exhibits broad protease substrate specificity. Braz. J. Med. Biol. Res. 34:1397-1403.
2. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
3. Belas, R., D. Erskine, and D. Flaherty. 1991. Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior. J. Bacteriol. 173:6279-6288.
4. Belas, R., D. Erskine, and D. Flaherty. 1991. Transposon mutagenesis in Proteus mirabilis. J. Bacteriol. 173:6289-6293.
5. Bensch, K. W., M. Raida, H. J. Magert, P. Schulz-Knappe, and W. G. Forssmann. 1995. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 368:331-335.
6. Bode, W., F. X. Gomis-Ruth, and W. Stockier. 1993. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins.' FEBS Lett. 331:134-140.
7. Cole, A. M., R. O. Darouicbe, D. Legarda, N. Connell, and G. Diamond. 2000. Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity. Antimicrob. Agents Chemother. 44:2039-2045.
8. Fairley, K. F., N. E. Carson, R. C. Guten, P. Leighton, A. D. Grounds, E. C. Laird, P. H. McCallum, R. L. Sleeman, and C. M. O'Keefe. 1971. Site of infection in acute urinary-tract infection in general practice. Lancet ii:615-618.
9. Ganz, T. 2001. Defensins in the urinary tract and other tissues. J. Infect. Dis. 183(Suppl. 1):S41-S42.
10. Gam, T. 2002. Immunology. Versatile defensins. Science 298:977-979.
11. Ghigo, J. M., and C. Wandersman. 1994. A carboxyl-terminal four-amino acid motif is required for secretion of the metalloprotease PrtG through the Erwinia chrysanthemi protease secretion pathway. J. Biol. Chem. 269:8979-8985.
12. Hege, T., and U. Baumann. 2001. Protease C of Erwinia chrysanthemi: the crystal structure and role of amino acids Y228 and E189. J. Mol. Biol. 314:187-193.
13. Johnson, D. E., R. G. Russell, C. V. Lockatell, J. C. Zulty, J. W. Warren, and H. L. Mobley. 1993. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. Immun. 61:2748-2754.
14. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Lehmann, J., M. Retz, J. Harder, M. Krams, U. Kellner, J. Hartmann, K. Hohgrawe, U. Raffenberg, M. Gerber, T. Loch, K. Weichert-Jacobsen, and M. Stockle. 18 Septembr 2002, posting date. Expression of human β-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect. Dis. 2:20. [Online.] http://www.biomedcentral.eom/1471-2334/2/20.
16. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
17. Loomes, L. M., B. W. Senior, and M. A. Kerr. 1992. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients. Infect. Immun. 60:2267-2273.
18. McCoy, A. J., H. Liu, T. J. Falla, and J. S. Gunn. 2001. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob. Agents Chemother. 45:2030-2037.
19. Mobley, H., and J. Warren. 1996. Urinary tract infections. ASM Press, Washington, D.C.
20. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. NCCLS, Wayne, PA.
21. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47:451-463.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual., 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Schmidtchen, A., I. M. Frick, E. Andersson, H. Tapper, and L. Bjorck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
24. Senior, B. W., M. Albrechtsen, and M. A. Kerr. 1987. Proteus mirabilis strains of diverse type have IgA protease activity. J. Med. Microbiol. 24:175-180.
25. Senior, B. W., M. Albrechtsen, and M. A. Kerr. 1988. A survey of IgA protease production among clinical isolates of Proteeae. J. Med. Microbiol. 25:27-31.
26. Valore, E. V., C. H. Park, A. J. Quayle, K. R. Wiles, P. B. McCray, Jr., and T. Ganz. 1998. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Investig. 101:1633-1642.
27. Walker, K. E., S. Moghaddame-Jafari, C. V. Lockatell, D. Johnson, and R. Belas. 1999. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol. Microbiol. 32:825-836.
28. Wassif, C., D. Cheek, and R. Belas. 1995. Molecular analysis of a metalloprotease from Proteus mirabilis. J. Bacteriol. 177:5790-5798.
29. Zaslof, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.